Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Doga C Gulhan, Ph.D.

Concepts (103)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Doga Gulhan's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Doga Gulhan has written about over time.
Nuclear Physics, 2 publications between 2014 and 2014, average publication date April 2014. Platinum Compounds, 1 publications between 2019 and 2019, average publication date April 2019. Adaptation, Physiological, 1 publications between 2019 and 2019, average publication date April 2019. Motion Perception, 1 publications between 2019 and 2019, average publication date April 2019. Pattern Recognition, Visual, 1 publications between 2019 and 2019, average publication date April 2019. Visual Fields, 1 publications between 2019 and 2019, average publication date April 2019. Neoplasms, 3 publications between 2019 and 2021, average publication date October 2020. Ovarian Neoplasms, 5 publications between 2019 and 2022, average publication date January 2021. Mutation, 7 publications between 2019 and 2022, average publication date April 2021. Deoxycytidine, 1 publications between 2021 and 2021, average publication date September 2021. BRCA1 Protein, 2 publications between 2021 and 2022, average publication date December 2021. Autistic Disorder, 1 publications between 2022 and 2022, average publication date July 2022. Mutagenesis, 1 publications between 2022 and 2022, average publication date July 2022. Point Mutation, 1 publications between 2022 and 2022, average publication date September 2022.

To see the data from this visualization as text, click here.
Gulhan's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (103)
Explore
_
Co-Authors (62)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.